Observational analysis highlights the role of beta-lactamase inhibitors in overcoming antimicrobial resistance, suggesting potential for improved cefepime efficacy.
Introduction Enmetazobactam, taniborbactam, and zidebactam are novel β-lactamase inhibitors that have been combined with cefepime in an effort to overcome common and emerging mechanisms of antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: